Abstract
Conducting intervention studies in Africa, where medicines supply for chronic conditions is inequitable and patchy, raises major ethical issues.
Here we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension.
Here we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension.
| Original language | English |
|---|---|
| Article number | e002193 |
| Journal | BMJ Global Health |
| Volume | 5 |
| Issue number | 7 |
| Early online date | 6 Jul 2020 |
| DOIs | |
| Publication status | Published - 6 Jul 2020 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Profiles
-
Max Bachmann
- Norwich Medical School - Professor of Health Services Research
- Norwich Institute for Healthy Aging - Member
- Public Health - Member
- Norwich Epidemiology Centre - Member
- Health Services and Primary Care - Member
Person: Research Group Member, Research Centre Member, Academic, Teaching and Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver